Abstrakt

Przypisy

• 1. Albright J.B., Bonatti H., Mendez J., Kramer D., Stauffer J., HinderR., Michel J.A., Dickson R.C., Hughes C., Nguyen J., Chua H., HellingerW.: Early and late onset Clostridium difficile-associated colitis followingliver transplantation. Transpl. Int., 2007; 20: 856-866
  Google Scholar
• 2. Alcala L., Martin A., Marin M., Sanchez-Somolinos M., Catalan P.,Pelaez T., Bouza E., Spanish Clostridium difficile Study Group.: Theundiagnosed cases of Clostridium difficile infection in a whole nation:where is the problem? Clin. Microbiol. Infect., 2012; 18: E204-E213
  Google Scholar
• 3. Ali M., Ananthakrishnan A.N., Ahmad S., Kumar N., Kumar G., SaeianK.: Clostridium difficile infection in hospitalized liver transplantpatients: a nationwide analysis. Liver Transpl., 2012; 18: 972-978
  Google Scholar
• 4. Apaydin S., Altiparmak M.R., Saribas S., Ozturk R.: Prevalence ofClostridium difficile toxin in kidney transplant recipients. Scand. J.Infect. Dis., 1998; 30: 542
  Google Scholar
• 5. Barbut F., Petit J.C.: Epidemiology of Clostridium difficile-associatedinfections. Clin. Microbiol. Infect., 2001; 7: 405-410
  Google Scholar
• 6. Bartlett J.G.: Antibiotic-associated diarrhea. N. Engl. J. Med., 2002;346: 334-339
  Google Scholar
• 7. Bartlett J.G., Gerding D.N.: Clinical recognition and diagnosis ofClostridium difficile infection. Clin. Infect. Dis., 2008; 46, Supp. 1: 12-18
  Google Scholar
• 8. Bauer M.P., Kuijper E.J., van Dissel J.T.: European Society of ClinicalMicrobiology and Infectious Diseases (ESCMID): treatment guidancedocument for Clostridium difficile infection (CDI). Clin. Microbiol.Infect., 2009; 15: 1067-1079
  Google Scholar
• 9. Bauer M.P., Notermans D.W., van Benthem B.H., Brazier J.S., WilcoxM.H., Rupnik M., Monnet D.L., van Dissel J.T., Kuijper E.J., ECDIS StudyGroup: Clostridium difficile infection in Europe: a hospital-based survey.Lancet, 2011; 377: 63-73
  Google Scholar
• 10. Biswal S.: Proton pump inhibitors and risk for Clostridium difficileassociated diarrhea. Biomed J., 2014; 37: 178-183
  Google Scholar
• 11. Boutros M., Al-Shaibi M., Chan G., Cantarovich M., Rahme E.,Paraskevas S., Deschenes M., Ghali P., Wong P., Fernandez M., GiannettiN., Cecere R., Hassanain M., Chaudhury P., Metrakos P.,Tchervenkov J., Barkun J.S.: Clostridium difficile colitis: increasingincidence, risk factors, and outcomes in solid organ transplant recipients.Transplantation, 2012; 93: 1051-1057
  Google Scholar
• 12. Czarkowski M.P, Cielebak E., Kondej B., Staszewska E.: Chorobyzakaźne i zatrucia w Polsce w 2012 roku. www.pzh.gov.pl (10.2013)
  Google Scholar
• 13. Davies K.A., Longshaw C.M., Davis G.L., Bouza E., Barbut F., BarnaZ., Delmée M., Fitzpatrick F., Ivanova K., Kuijper E., Macovei I.S.,Mentula S., Mastrantonio P., von Müller L., Oleastro M., Petinaki E.,Pituch H., et al.: Underdiagnosis of Clostridium difficile across Europe:the European, multicentre, prospective, biannual, point-prevalencestudy of Clostridium difficile infection in hospitalised patients withdiarrhoea (EUCLID). Lancet Infect. Dis., 2014; 14: 1208-1219
  Google Scholar
• 14. Dubberke E.R., Burdette S.D.: Clostridium difficile infections insolid organ transplantation. Am. J. Transpl., 2013; 13, Suppl. 4: 42-49
  Google Scholar
• 15. Dubberke E.R., Riddle D.J.: Clostridium difficile in solid organ transplantrecipients. Am. J. Transplant., 2009; 9, Suppl. 4: 35-40
  Google Scholar
• 16. FDA Drug Safety Communication: Clostridium difficile-associateddiarrhea can be associated with stomach acid drugs known as protonpump inhibitors (PPIs). http://www.fda.gov/drugs/drugsafety/ucm290510.htm (10.2013)
  Google Scholar
• 17. Fekety R., McFarland L.V., Surawicz C.M., Greenberg R.N., ElmerG.W., Mulligan M.E.: Recurrent Clostridium difficile diarrhea: characteristicsof and risk factors for patients enrolled in a prospective,randomized, double-blinded trial. Clin. Infect. Dis., 1997; 24: 324-333
  Google Scholar
• 18. Gerding D.N., Lessa F.C.: The epidemiology of Clostridium difficileinfection inside and outside health care institutions. Infect. Dis. Clin.North. Am., 2015; 29: 37-50
  Google Scholar
• 19. Ho M., Yang D., Wyle F.A., Mulligan M.E.: Increased incidence ofClostridium difficile-associated diarrhea following decreased restrictionof antibiotic use. Clin. Infect. Dis., 1996; 23: 102-106
  Google Scholar
• 20. Hubert B., Loo V.G., Bourgault A.M., Poirier L., Dascal A., FortinE., Dionne M., Lorange M.: A portrait of the geographic disseminationof the Clostridium difficile North American pulsed-field type 1strain and the epidemiology of C. difficile-associated disease in Qué-bec. Clin. Infect. Dis., 2007; 44: 238-244
  Google Scholar
• 21. Kelly C.P., LaMont J.T.: Clostridium difficile infection. Annu. Rev.Med., 1998; 49: 375-390
  Google Scholar
• 22. Keven K., Basu A., Re L., Tan H., Marcos A., Fung J.J., Starzl T.E.,Simmons R.L.: Clostridium difficile colitis in patients after kidney andpancreas-kidney transplantation. Transpl. Infect. Dis., 2004; 6: 10-14
  Google Scholar
• 23. Khanna S., Pardi D.S.: Clostridium difficile infection: new insightsinto management. Mayo Clin. Proc., 2012; 87: 1106-1117
  Google Scholar
• 24. Khanna S., Pardi D.S.: Clostridium difficile infection: managementstrategies for a difficult disease. Therap. Adv. Gastroenterol.,2014; 7: 72-86
  Google Scholar
• 25. Khanna S., Pardi D.S.: The growing incidence and severity ofClostridium difficile infection in inpatient and outpatient settings.Expert Rev. Gastroenterol. Hepatol., 2010; 4: 409-416
  Google Scholar
• 26. Kuijper E.J., Barbut F., Brazier J.S., Kleinkauf N., Eckmanns T.,Lambert M.L., Drudy D., Fitzpatrick F., Wiuff C., Brown D.J., Coia J.E.,Pituch H., Reichert P., Even J., Mossong J., et.al: Update of Clostridiumdifficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill.,2008; 13: 1-7
  Google Scholar
• 27. Kuijper E.J., Coignard B., Brazier J.S., Suetens C., Drudy D., WiuffC., Pituch H., Reichert P., Schneider F., Widmer A.F., Olsen K.E.,Allerberger F., Notermans D.W., Barbut F., Delmée M., et.al.: Updateof Clostridium difficile-associated disease due to PCR ribotype 027 inEurope. Euro Surveill., 2007; 12: E1-E2
  Google Scholar
• 28. Kuijper E.J., Coignard B., Tüll P.; ESCMID Study Group for Clostridiumdifficile; EU Member States; European Centre for DiseasePrevention and Control: Emergence of Clostridium difficile-associateddisease in North America and Europe. Clin. Microbiol. Infect., 2006;12, Suppl. 6: 2-18
  Google Scholar
• 29. Leonard J., Marshall J.K., Moayyedi P.: Systematic review of therisk of enteric infection in patients taking acid suppression. Am. J.Gastroeneterol., 2007; 102: 2047-2056
  Google Scholar
• 30. Lucado J., Gould C., Elixhauser A.: Clostridium difficile infections(CDI) in hospital stays, 2009. Statistical brief #124. Healthcare Costand Utilization Project (HCUP) Statistical Briefs, [Internet]. Rockville(MD): Agency for Health Care Policy and Research (US); 2006- 2012 Jan
  Google Scholar
• 31. Lyerly D.M., Barroso L.A., Wilkins T.D., Depitre C., Corthier G.:Characterization of a toxin A-negative, toxin B-positive strain ofClostridium difficile. Infect. Immun., 1992; 60: 4633-4639
  Google Scholar
• 32. McDonald L.C., Killgore G.E., Thompson A., Owens R.C. Jr., KazakovaS.V., Sambol S.P., Johnson S., Gerding D.N.: An epidemic, toxingene-variant strain of Clostridium difficile. N. Engl. J. Med., 2005; 353:2433-2441
  Google Scholar
• 33. McFarland L.V., Mulligan M.E., Kwok R.Y., Stamm W.E.: Nosocomialacquisition of Clostridium difficile infection. N. Engl. J. Med.,1989; 320: 204-210
  Google Scholar
• 34. Mertz D., Frei R., Plagge H., Battegay M., Widmer A.F.: Strongercorrelation between antibiotic use and the incidence of Clostridiumdifficile determined by culture results instead of faecal toxin detectiononly. Eur. J. Clin. Microbiol. Infect. Dis., 2010; 29: 1575-1578
  Google Scholar
• 35. Mitu-Pretorian O.M, Forgacs B., Qumruddin A., Tavakoli A., AugustineT., Pararajasingam R.: Outcomes of patients who developsymptomatic Clostridium difficile infection after solid organ transplantation.Transplant. Proc., 2010; 42: 2631-2633
  Google Scholar
• 36. Moyenuddin M., Williamson J.C., Ohl C.A.: Clostridium difficile–associated diarrhea: current strategies for diagnosis and therapy.Curr. Gastroenetrol. Rep., 2002; 4: 279-286
  Google Scholar
• 37. Niemczyk M., Leszczyński P., Wyzgał J., Paczek L., Krawczyk M.,Luczak M.: Infections caused by Clostridium difficile in kidney or livergraft recipients. Ann. Transplant., 2005; 10: 70-74
  Google Scholar
• 38. Noblett S.E., Welfare M., Seymour K.: The role of surgery in Clostridiumdifficile colitis. Br. Med. J., 2009; 338: 1563
  Google Scholar
• 39. Olsen M.A., Yan Y., Reske K.A., Zilberberg M.D., Dubberke E.R.:Recurrent Clostridium difficile infection is associated with increasedmortality. Clin. Microbiol. Infect., 2015; 21: 164-170
  Google Scholar
• 40. Origüen J., Fernández-Ruiz M., Lumbreras C., Orellana M.Á., Ló-pez-Medrano F., Ruiz-Merlo T., San Juan R., García-Reyne A., GonzálezE., Polanco N., Paz-Artal E., Andrés A., Aguado J.M.: Potential role ofpost-transplant hypogammaglobulinemia in the risk of Clostridiumdifficile infection after kidney transplantation: a case-control study.Infection, 2015; 43: 413-422
  Google Scholar
• 41. Pépin J., Valiquette L., Alary M.E., Villemure P., Pelletier A., ForgetK., Pepin K., Chouinard D.: Clostridium difficile associated diarrheain a region of Quebec from 1991 to 2003: a changing pattern ofdisease severity. CMAJ, 2004; 171: 466-472
  Google Scholar
• 42. Pituch H., Obuch-Woszczatyński P., Lachowicz D., MłynarczykG., Wultańska D., Kuijper E.: First results of a polish surveillanceprogramme to Clostridium difficile infections. High prevalence ofClostridium difficile PCR ribotype 027. 23rd European Congress ofClinical Microbiology and Infectious Diseases (ECCMID): Abstract.Presented April 30, 2013
  Google Scholar
• 43. Reveles K.R., Lee G.C., Boyd N.K., Frei C.R.: The rise in Clostridiumdifficile infection incidence among hospitalized adults in theUnited States: 2001-2010. Am. J. Infect. Control., 2014; 42: 1028-1032
  Google Scholar
• 44. Riggs M.M., Sethi A.K., Zabarsky T.F., Eckstein E.C., Jump R.L.,Donskey C.J.: Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strainsamong long-term care facility residents. Clin. Infect. Dis., 2007; 45:992-998
  Google Scholar
• 45. Shah K., Pass L.A., Cox M., Lanham M., Arnold F.W.: Evaluatingcontemporary antibiotics as a risk factor for Clostridium difficile infectionin surgical trauma patients. Trauma Acute Care Surg., 2012;72: 691-695
  Google Scholar
• 46. Shah S.A., Tsapepas D.S., Kubin C.J., Martin S.T., Mohan S., RatnerL.E., Pereira M., Kapur S., Dadhania D., Walker-McDermott J.K.:Risk factors associated with Clostridium difficile infection after kidneyand pancreas transplantation. Transpl. Infect. Dis., 2013; 15: 502-509
  Google Scholar
• 47. Simor A.E, Bradley S.F., Strausbaugh L.J., Crossley K., Nicolle L.E.:Clostridium difficile in long term care facilities for the elderly. Infect.Control Hosp. Epidemiol., 2002; 23: 696-703
  Google Scholar
• 48. Stelzmueller I., Goegele H., Biebl M., Wiesmayr S., Berger N.,Tabarelli W., Ruttmann E., Albright J., Margreiter R., Fille M., BonattiH.: Clostridium difficile colitis in solid organ transplantation- a singlecenterexperience. Dig. Dis. Sci., 2007; 52: 3231-3236
  Google Scholar
• 49. Tsapepas D.S., Martin S.T., Miao J., Shah S.A., Scheffert J., FesterK., Ma K., Lat A., Egan R., McKeen J.T.: Clostridium difficile infection,a descriptive analysis of solid organ transplant recipients at a singlecenter. Diagn. Microbiol. Infect. Dis., 2015; 81: 299-304
  Google Scholar
• 50. Viscidi R., Willey S., Bartlett J.G.: Isolation rates and toxigenicpotential of Clostridium difficile isolates from various patient populations.Gastroenterology, 1981; 81: 5-9
  Google Scholar
• 51. West M., Pirenne J., Chavers B., Gillingham K., Sutherland D.,Dunn D., Matas A.: Clostridium difficile colitis after kidney and kidney-pancreastransplantation. Clin. Transplant., 1999; 13: 318-323
  Google Scholar
• 52. Wistrom J., Norrby S.R., Myhre E.B., Eriksson S., Granstrom G.,Lagergren L., Englund G., Nord C.E., Svenungsson B.: Frequency ofantibiotic associated diarrhoea in 2462 antibiotic-treated hospitalizedpatients: a prospective study. J. Antimicrob. Chemother., 2001;47: 43-50
  Google Scholar

Pełna treść artykułu